Shield Therapeutics plc carries a market capitalization of 81.50M, placing it among publicly traded companies globally.
| Market Cap | 81.50M |
| Enterprise Value | N/A |
Shield Therapeutics plc's stock has gained approximately 97.92208% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | 97.92208% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Shield Therapeutics plc's most recent stock split took place on December 28, 2022 with a 1000:1029 split ratio.
| Last Split Date | 12/28/2022 |
| Split Ratio | 1000:1029 |